
    
      Patients programmed to undergo PTA due to angiographically-proven infrapopliteal arterial
      disease in our department will be randomized in the above mentioned study arms. The studies
      primary endpoint will be assessed with the use of intra-arterial digital subtracted
      angiography and subsequent Quantitative Vascular Analysis (QVA) analysis.Clinical follow-up
      is set at 1, 3 and 6 months. Patients' baseline demographics and procedural details will be
      recorded and analyzed.
    
  